The role of leukotriene B4 in allergic diseases

Allergology International

Volumn 57, Issue 4, 2008, Pages 291-298

  Ohnishi, Hiroshi ^a   Miyahara, Nobuaki ^b   Gelfand, Erwin W ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Allergic conjunctivitis; Allergic rhinitis; Asthma; Atopic dermatitis

Indexed keywords

ACETYLSALICYLIC ACID; CHEMOKINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYTOKINE; ETALOCIB; FATTY ACID; FISH OIL; FLUOROMETHOLONE; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LODOXAMIDE; PEPTIDOLEUKOTRIENE; ZILEUTON;

ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC DISEASE; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ASPIRIN SENSITIVE ASTHMA; ASTHMA; ATOPIC DERMATITIS; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG MEGADOSE; EXERCISE INDUCED ASTHMA; HUMAN; LIPID DEGRADATION; LIPOGENESIS; MEMORY T LYMPHOCYTE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 59549104762     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.08-RAI-0019     Document Type: Review

References (77)

1. Yokomizo T, Izumi T, Shimizu T. Leukotriene B4: metabolism and signal transduction. Arch Biochem Biophys 2001;385:231-41.
2. Luster AD, Tager AM. T-cell trafficking in asthma: lipid mediators grease the way. Nat Rev Immunol 2004;4:711-24.
3. Murphy RC, Gijón MA. Biosynthesis and metabolism of leukotrienes. Biochem J 2007;405:379-95.
4. O'Driscoll BP, Cromwell O, Kay AB. Sputum leukotrienes in obstructive airways diseases. Clin Exp Immunol 1984; 55:397-404.
5. Wardlaw AJ, Hay H, Cromwell O, Collins JV, Kay AB. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989;84:19-26.
6. Shindo K, Matsumoto Y, Hirai Y et al. Measurement of leukotriene B4 in arterial blood of asthmatic patients during wheezing attacks. J Intern Med 1990;228:91-6.
7. Meltzer SS, Hasday JD, Cohn J, Bleecker ER Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 1996; 153:931-5.
8. 4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. Blood 2006;107:444-53.
9. 4: novel interactions in the persistence and progression of asthma. J Allergy Clin Immunol 2006;117:577-82.
10. Shaw RJ, Fitzharris P, Cromwell O, Wardlaw AJ, Kay AB. Allergen-induced release of sulphidopeptide leukotrienes (SRS-A) and LTB4 in allergic rhinitis. Allergy 1985;40:1-6.
11. Meslier N, Braunstein G, Lacronique J et al. Local cellular and humoral responses to antigenic and distilled water challenge in subjects with allergic rhinitis. Am Rev Respir Dis 1988;137:617-24.
12. Knapp HP, Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 1990;323:1745-8.
13. Kumar NS, Schaefer PA, Lárk G, Frieri M. Late phase response during nasal challenge: effect of astemizole on leukotriene B4 levels. Allergy Asthma Proc 1996;17:93-9.
14. Ruzicka T, Simmet T, Peskar BA, Ping J. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 1986;86:105-8.
15. Fogh K, Herlin T, Kragballe K. Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. J Allergy Clin Immunol 1989; 83:450-5.
16. Reilly DM, Parslew R, Sharpe GR, Powell S, Green MR. Inflammatory mediators in normal, sensitive and diseased skin types. Acta Derm Venereol 2000;80:171-4.
17. Nathan H, Naveh N, Meyer E. Levels of prostaglandin E2 and leukotriene B4 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin. Doc Ophthalmol 1994;85:247-57.
18. Akman A, Irkeç M, Orhan M. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal, keratoconjunctivitis. Eye 1998;12: 291-5.
19. Hashimoto A, Endo H, Hayashi I et al. Differential expression of leukotriene B4 receptor subtypes (BLT1 and BLT2) in human synovial tissues and synovial fluid leukocytes of patients with rheumatoid arthritis. J Rheumatol 2003;30:1712-8.
20. Seggev JS, Thornton WH Jr, Edes TE. Serum leukotriene B4 levels in patients with obstructive pulmonary disease. Chest 1991; 99:289-91.
21. Kostikas E, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005;127:1553-9.
22. Medoff BD, Seung E, Wain JC et al. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J Fxp Med 2005;202: 97-110.
23. Wilborn J, Bailie M, Coffey M, Burdick M, Strieter R, Peters-Golden M. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1996; 97:1827-36.
24. Kowal-Bielecka O, Distler O, Kowal K et al. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease. Arthritis Rheum 2003; 48:1639-46.
25. Sampson AP, Castling DP, Green CP, Price JF. Persistent increase in plasma and urinary leukotrienes after acute asthma. Arch Dis Child 1995;73:221-5.
26. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002;166:1345-9.
27. Hilberg T, Deigner HP, Möller E et al. Transcription in response to physical stress - clues to the molecular mechanisms of exercise-induced asthma. FASEB J 2005; 19:1492-4.
28. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. Inhibition of monocyte leukotriene B4 production after aspirin desensitization. J Allergy Clin Immunol 1995;96:148-56.
29. Wilkinson JR, Crea AE, Clark TJ, Lee TH. Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma. J Clin Invest 1989; 84:1930-41.
30. Freeland HS, Pipkorn U, Schleimer RP et al. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol 1989;83:634-42.
31. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149:953-9.
32. Azevedo I, de Blic J, Scheinmann P, Vargaftig BB, Bachelet M. Enhanced arachidonic acid metabolism in alveolar macrophages from wheezy infants. Modulation by dexamethasone. Am J Respir Crit Care Med 1995; 152:1208-14.
33. Frieri M, Therattil J, Chavarria V et al. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1998; 81:431-7.
34. Shahab R, Phillips DE, Jones AS. Prostaglandins, leukotrienes and perennial rhinitis. J Laryngol Otol 2004;118: 500-7.
35. Colville-Nash P, Willis D, Papworth J et al. The peroxisome proliferator-activated receptor alpha activator, Wy 14,643, is anti-inflammatory in vivo. Inflammopharmacology 2005; 12:493-504.
36. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 1996;384:39-43.
37. Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 1997;387:620-4.
38. Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T. A second leukotriene B4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 2000;192:421-32.
39. Iizuka Y, Yokomizo T, Terawaki K, Komine M, Tamaki K, Shimizu T. Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J Biol Chem 2005;280:24816-23.
40. Lundeen KA, Sun B, Karlsson L, Fourie AM. Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells. J Immunol 2006;177:3439-47.
41. Huang L, Zhao A, Wong F et al. Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler Thromb Vasc Biol 2004;24:1783-8.
42. 4 receptor 1. J Allergy Clin Immunol 2008;121:864-71.e4.
43. Zaitsu M, Hamasaki Y, Matsuo M, Ichimaru T, Fujita I, Ishii E. Leukotriene synthesis is increased by transcriptional up-regulation of 5-lipoxygenase, leukotriene A4 hydrolase, and leukotriene C4 synthase in asthmatic children. J Asthma 2003;40:147-54.
44. Pacheco Y, Hosni R, Chabannes B et al. Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy. Eur J Clin Invest 1992;22:732-9.
45. Nowak D, Grimminger F, Jörres R et al. Increased LTB4 metabolites and PGD2 in BAL fluid after methacholine challenge in asthmatic subjects. Eur Respir J 1993;6:405-12.
46. Wenzel SE, Trudeau JB, Westcott JY, Beam WR, Martin RJ. Single oral dose of prednisone decreases leukotriene B4 production by alveolar macrophages from patients with nocturnal asthma but not control subjects: relationship to changes in cellular influx and FEV1. J Allergy Clin Immunol 1994;94:870-81.
47. Wenzel SE, Trudeau JB, Kaminsky DA, Cohn J, Martin RJ, Westcott JY. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995;152:897-905.
48. Henderson WR Jr, Lewis DB, Albert RK et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 1996;184:1483-94.
49. Fischer AR, McFadden CA, Frantz R et al. Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects. Am J Respir Crit Care Med 1995;152:1203-7.
50. Evans DJ, Barnes PJ, Spaethe SM, van Alstyne EL, Mitchell MI, O'Connor BJ. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma. Thorax 1996; 51:1178-84.
51. Asanuma F, Kuwabara K, Arimura A, Furue Y, Fleisch JH, Hori Y. Effects of leukotriene B4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs. Inflamm Res 2001;50:136-41.
52. Turner CR, Breslow R, Conklyn MJ et al. In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma. J Clin Invest 1996;97:381-7.
53. 4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 2003;4:982-90.
54. + T cells and airway hyperresponsiveness. J Immunol 2005;174:4979-84.
55. 4 receptor 1 in allergen-induced airway hyperresponsiveness. Am J Resp Crit Care Med 2005;172: 161-7.
56. 4 receptor 1 confers resistance to airway hyper-responsiveness and Th2-type immune responses. J Immunol 2005;175:4217-25.
57. + T cell-mediated, mast cell-dependent airway hyperresponsiveness. J Immunol 2006;176:3157-64.
58. Miyahara N, Miyahara S, Takeda K, Gelfand EW. Role of the LTB4/BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation. Allergol Int 2006; 55:91-7.
59. Arm JP, Horton CE, House F, Clark TJ, Spur BW, Lee TH. Enhanced generation of leukotriene B4 by neutrophils stimulated by unopsonized zymosan and by calcium ionophore after exercise-induced asthma. Am Rev Respir Dis 1988;138:47-53.
60. Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 2006;129: 39-49.
61. Pinto S, Gallo O, Polli G et al. Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Prostaglandins Leukot Essent Fatty Acids 1997;57:533-7.
62. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002; 347:1493-9.
63. Chabannes B, Hosni R, Molière P et al. Leukotriene B4 level in neutrophils from allergic and healthy subjects stimulated by low concentration of calcium ionophore A23187. Effect of exogenous arachidonic acid and possible endogenous source. Biochim Biophys Acta 1991; 1093:47-54.
64. Baroody FM, Naclerio RM. Antiallergic effects of H1-receptor antagonists. Allergy 2000;55 Suppl 64:17-27.
65. Ruzicka T, Ring J. Enhanced releasability of prostaglandin E2 and leukotrienes B4 and C4 from leukocytes of patients with atopic eczema. Acta Derm Venereol 1987;67: 469-75.
66. Okano-Mitani H, Ikai K, Imamura S. Leukotriene A4 hydrolase in peripheral leukocytes of patients with atopic dermatitis. Arch Dermatol Res 1996;288:168-72.
67. Spada CS, Woodward DF, Hawley SB, Nieves AL. Leukotrienes cause eosinophil emigration into conjunctival tissue. Prostaglandins 1986;31:795-809.
68. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000; 71:343S-8S.
69. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007;178:3912-7.
70. Payan DG, Wong MY, Chernov-Rogan T et al. Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J Clin Immunol 1986;6:402-10.
71. Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH. The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis 1989; 139:1395-400.
72. Hoshino M, Nakamura Y, Sim JJ, Tomioka H. A comparative study of the effects of ketotifen, disodium cromoglycate, and beclomethasone dipropionate on bronchial mucosa and asthma symptoms in patients with atopic asthma. Respir Med 1998;92:942-50.
73. Caproni M, Torchia D, Antiga E et al. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. Br J Dermatol 2007;156:312-9.
74. Backman KS, Greenberger PA, Patterson R. Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'. Chest 1997;112:1234-40.
75. van Rensen EL, Sont JK, Evertse CE et al. Bronchial CD8 cell infiltrate and lung function decline in asthma. Am J Respir Crit Care Med 2005;172:837-41.
76. Stankova J, Turcotte S, Harris J, Rola-Pleszczynski M. Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival. J Immunol 2002; 168:3570-6.
77. Pettersson A, Sabirsh A, Bristulf J et al. Pro- and anti-inflammatory substances modulate expression of the leukotriene B4 receptor, BLT1, in human monocytes. J Leukoc Biol 2005; 77:1018-25.